Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

73 ARTÍCULOS , VIENDO DEL 61 AL 73

The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease

Zhang B, Xu Y, Zhu B, Kantarci K.

CNS Neurosci Ther. 2014 Jan;20(1):3-9. doi: 10.1111/cns.12166. Epub 2013 Dec 12.

On the relation among mood, apathy, and anosognosia in Alzheimer's disease

Mograbi DC, Morris RG.

J Int Neuropsychol Soc. 2014 Jan;20(1):2-7. doi: 10.1017/S1355617713001276. Epub 2013 Dec 13.

Is there a link between gynecologic surgeries and Alzheimer disease?

Rocca WA, Henderson VW.

Neurology. 2014 Jan 21;82(3):196-7. doi: 10.1212/WNL.0000000000000043. Epub 2013 Dec 11.

TREM2 and the neuroimmunology of Alzheimer's disease

Hickman SE, El Khoury J.

Biochem Pharmacol. 2014 Apr 15;88(4):495-8. doi: 10.1016/j.bcp.2013.11.021. Epub 2013 Dec 16.

Alzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategies

Gandy S.

Biol Psychiatry. 2014 Apr 1;75(7):553-7. doi: 10.1016/j.biopsych.2013.11.019. Epub 2013 Nov 28.

A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations

Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; ADNI.

Hum Brain Mapp. 2014 Apr;35(4):1226-36. doi: 10.1002/hbm.22247. Epub 2013 Feb 21.

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

Blennow K, Hampel H, Zetterberg H.

Neuropsychopharmacology. 2014 Jan;39(1):189-201. doi: 10.1038/npp.2013.154. Epub 2013 Jun 25.

Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum

Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA; Alzheimer Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1168-79. doi: 10.1016/j.jagp.2013.03.006. Epub 2013 Jul 24.

Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease

Santos RR, Torres KC, Lima GS, Fiamoncini CM, Mapa FC, Pereira PA, Rezende VB, Martins LC, Bicalho MA, Moraes EN, Reis HJ, Teixeira AL, Romano-Silva MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:1-5. doi: 10.1016/j.pnpbp.2013.06.019. Epub 2013 Jul 25.

Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology

Obulesu M, Jhansilakshmi M.

Int J Neurosci. 2014 Apr;124(4):227-35. doi: 10.3109/00207454.2013.831852. Epub 2013 Sep 12.

CD33 in Alzheimer's disease

Jiang T, Yu JT, Hu N, Tan MS, Zhu XC, Tan L.

Mol Neurobiol. 2014 Feb;49(1):529-35. doi: 10.1007/s12035-013-8536-1. Epub 2013 Aug 28.

CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility

Raj T, Ryan KJ, Replogle JM, Chibnik LB, Rosenkrantz L, Tang A, Rothamel K, Stranger BE, Bennett DA, Evans DA, De Jager PL, Bradshaw EM.

Hum Mol Genet. 2014 May 15;23(10):2729-36. doi: 10.1093/hmg/ddt666. Epub 2013 Dec 30.

Resting-state networks in Alzheimer's disease and Parkinson's disease

Rektorova I.

Neurodegener Dis. 2014;13(2-3):186-8. doi: 10.1159/000354237. Epub 2013 Sep 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias